First Wave BioPharma Inc. Skyrocketed
Thu, Dec 29, 2022 at 07:12 PM
First Wave BioPharma Inc. (FWBI:NASDAQ) soared at $0.79, a gain of 61.2%. On Thu, Dec 29, 2022, FWBI:NASDAQ touched a New 2-Week High of $0.79. The stock appeared on our News Catalysts scanner on Mon, Dec 12, 2022 at 09:14 AM in the 'MISCELLANEOUS' category. From Thu, Dec 15, 2022, the stock recorded 33.33% Up Days and 40.00% Green Days
The stock spiked on Wed, Oct 05, 2022 at $2.34 with a volume of 1M+.
About First Wave BioPharma Inc. (FWBI:NASDAQ)
First Wave BioPharma Inc is a clinical stage biopharmaceutical company specializing in the development of targeted, non-systemic therapies for gastrointestinal diseases.
Top 10 Gainers:
- Hoth Therapeutics, Inc. (HOTH:NASDAQ), 143.64%
- Kala Pharmaceuticals, Inc. (KALA:NASDAQ), 99.04%
- Palisade Bio Inc. (PALI:NASDAQ), 77.9%
- SatixFy Communications Ltd. (SATX:NYSEMKT), 67.68%
- First Wave BioPharma Inc. (FWBI:NASDAQ), 61.22%
- Baudax Bio, Inc. (BXRX:NASDAQ), 56.09%
- Quotient Limited (QTNT:NASDAQ), 54.13%
- Starry Group Holdings Inc. Class A (STRY:NYSE), 49.75%
- Mercurity Fintech Holding Inc. (MFH:NASDAQ), 45.57%
- Sonendo Inc. (SONX:NYSE), 39.11%